MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors (like colorectal, lung, or pancreatic cancer) that have lost a specific marker on their cells. The treatment uses the patient's own immune cells, modified to target cancer cells while protecti…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug, SW-682, in adults with advanced solid tumors that have not responded to standard treatments. The study focuses on cancers with specific genetic changes in the Hippo pathway. The goal is to find a safe dose and see if the drug can shri…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New CAR t therapy targets three tough cancers in early trial
Disease control Recruiting nowThis early-stage study tests a one-time treatment called SynKIR-110, made from a patient's own immune cells modified to attack cancer cells that have a protein called mesothelin. It is for adults with advanced ovarian cancer, bile duct cancer, or mesothelioma that has come back a…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:25 UTC
-
New surgery aims to ease suffering in incurable lung cancer
Symptom relief Recruiting nowThis study looks at whether a surgery to remove part of the lung lining (partial pleurectomy) can help reduce symptoms and improve quality of life in people with advanced pleural mesothelioma that cannot be fully removed. About 30 participants will have the surgery and fill out s…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
New study gathers key materials for Next-Gen cancer therapy
Knowledge-focused Recruiting nowThis observational study collects tumor tissue and blood cells from 200 adults with advanced solid tumors like colorectal, lung, or pancreatic cancer. The goal is to understand how often tumors lose a specific marker (HLA) and to store participants' own T cells for possible futur…
Matched conditions: MESOTHELIOMA, MALIGNANT
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC